63 related articles for article (PubMed ID: 28412068)
1. Vitreous Amyloidosis: Ocular, Systemic, and Genetic Insights.
Venkatesh P; Selvan H; Singh SB; Gupta D; Kashyap S; Temkar S; Gogia V; Tripathy K; Chawla R; Vohra R
Ophthalmology; 2017 Jul; 124(7):1014-1022. PubMed ID: 28412068
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein AI-Derived Vitreous Amyloidosis: An Elusive Diagnosis.
Yepez JB; Murati FA; Petitto M; De Yepez J; Galue JM; Vinardell S; Mura M; Arevalo JF
Case Rep Ophthalmol; 2020; 11(2):287-292. PubMed ID: 32774294
[TBL] [Abstract][Full Text] [Related]
3. Vitreoretinal Lymphoma with Intraretinal Infiltration, Simulating Retinal Necrosis.
Guan WX; Peng XY
Ophthalmol Retina; 2024 Jun; 8(6):571-578. PubMed ID: 38040056
[TBL] [Abstract][Full Text] [Related]
4. An audit of retinal lymphoma treatment at the University of California San Francisco.
Damato B; Bever GJ; Kim DJ; Afshar AR; Rubenstein JL
Eye (Lond); 2020 Mar; 34(3):515-522. PubMed ID: 31358925
[TBL] [Abstract][Full Text] [Related]
5. Localized conjunctival amyloidosis clinically presenting as pyogenic granuloma.
Amir A; Amir B; Rabah R; Sheikh S
J Surg Case Rep; 2024 May; 2024(5):rjae356. PubMed ID: 38817793
[TBL] [Abstract][Full Text] [Related]
6. Ocular Manifestations of Familial Transthyretin Amyloidosis.
Reynolds MM; Veverka KK; Gertz MA; Dispenzieri A; Zeldenrust SR; Leung N; Pulido JS
Am J Ophthalmol; 2017 Nov; 183():156-162. PubMed ID: 28911993
[TBL] [Abstract][Full Text] [Related]
7. Amyloid detection in the transverse carpal ligament of patients with hereditary ATTR V30M amyloidosis and carpal tunnel syndrome.
Samões R; Taipa R; Valdrez K; Gonçalves I; Melo Pires M; Martins da Silva A; Coelho T
Amyloid; 2017 Jun; 24(2):73-77. PubMed ID: 28413892
[TBL] [Abstract][Full Text] [Related]
8. Amyloidosis and Ocular Involvement: an Overview.
Dammacco R; Merlini G; Lisch W; Kivelä TT; Giancipoli E; Vacca A; Dammacco F
Semin Ophthalmol; 2020 Jan; 35(1):7-26. PubMed ID: 31829761
[No Abstract] [Full Text] [Related]
9. [The ocular involvement in the transthyretin-related familial amyloid polyneuropathy].
Lin HY; Dai RP
Zhonghua Yan Ke Za Zhi; 2017 Oct; 53(10):783-785. PubMed ID: 29050191
[TBL] [Abstract][Full Text] [Related]
10. Transthyretin deposition in the eye in the era of effective therapy for hereditary ATTRV30M amyloidosis.
Buxbaum JN; Brannagan T; Buades-Reinés J; Cisneros E; Conceicao I; Kyriakides T; Merlini G; Obici L; Plante-Bordeneuve V; Rousseau A; Sekijima Y; Imai A; Waddington Cruz M; Yamada M
Amyloid; 2019 Mar; 26(1):10-14. PubMed ID: 30675806
[TBL] [Abstract][Full Text] [Related]
11. Ocular Manifestations of Familial Transthyretin Amyloidosis.
Tripathy K; Chawla R; Selvan H; Venkatesh P
Am J Ophthalmol; 2018 Feb; 186():169-170. PubMed ID: 29217097
[No Abstract] [Full Text] [Related]
12. OCULAR MANIFESTATIONS OF SYSTEMIC AMYLOIDOSIS.
Reynolds MM; Veverka KK; Gertz MA; Dispenzieri A; Zeldenrust SR; Leung N; Pulido JS
Retina; 2018 Jul; 38(7):1371-1376. PubMed ID: 29068915
[TBL] [Abstract][Full Text] [Related]
13. Small gauge vitrectomy for vitreous amyloidosis and subsequent management of secondary glaucoma in patients with hereditary transthyretin amyloidosis.
Kakihara S; Hirano T; Imai A; Miyahara T; Murata T
Sci Rep; 2020 Mar; 10(1):5574. PubMed ID: 32221479
[TBL] [Abstract][Full Text] [Related]
14. Angiographic Signatures of the Predominant Form of Familial Transthyretin Amyloidosis (Val30Met Mutation).
Rousseau A; Terrada C; Touhami S; Barreau E; Rothschild PR; Valleix S; Benoudiba F; Errera MH; Cauquil C; Guiochon-Mantel A; Adams D; Labetoulle M
Am J Ophthalmol; 2018 Aug; 192():169-177. PubMed ID: 29859145
[TBL] [Abstract][Full Text] [Related]
15. Amyloidosis as a Systemic Disease in Context.
Cuddy SAM; Falk RH
Can J Cardiol; 2020 Mar; 36(3):396-407. PubMed ID: 32145867
[TBL] [Abstract][Full Text] [Related]
16. Neuropathy Associated with Systemic Amyloidosis.
Kaku M; Berk JL
Semin Neurol; 2019 Oct; 39(5):578-588. PubMed ID: 31639841
[TBL] [Abstract][Full Text] [Related]
17. Assessment of patients with hereditary transthyretin amyloidosis - understanding the impact of management and disease progression.
Conceição I; Coelho T; Rapezzi C; Parman Y; Obici L; Galán L; Rousseau A
Amyloid; 2019 Sep; 26(3):103-111. PubMed ID: 31339362
[TBL] [Abstract][Full Text] [Related]
18. [Role of vitrectomy in suspected vitreous amyloidosis].
Morice C; Dutheil C; Rougier MB; Delyfer MN; Korobelnik JF; Léger F
J Fr Ophtalmol; 2019 Dec; 42(10):e463-e464. PubMed ID: 31253434
[No Abstract] [Full Text] [Related]
19. Nd:YAG capsulotomy for the management of posterior capsular amyloidosis.
Mansukhani SA; Pulido JS; Khanna SS
Am J Ophthalmol Case Rep; 2019 Mar; 13():50-52. PubMed ID: 30560216
[TBL] [Abstract][Full Text] [Related]
20. Visualization of multiple organ amyloid involvement in systemic amyloidosis using
Ezawa N; Katoh N; Oguchi K; Yoshinaga T; Yazaki M; Sekijima Y
Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):452-461. PubMed ID: 28891012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
